Literature DB >> 2323034

Developmental brain abnormalities accompanied with the retarded production of S-100 beta protein in genetic polydactyly mice.

I Naruse1, K Kato, T Asano, F Suzuki, Y Kameyama.   

Abstract

The homozygotes of a mouse strain with genetic polydactyly (Polydactyly Nagoya, Pdn) exhibit various brain malformations including exencephaly in about 20%. In the present report, the brains of homozygotes (Pdn/Pdn) which were not exencephalic were examined morphologically and biochemically. Homozygous newborn brains showed hydrocephaly, some gyri on the cerebral hemisphere, absence of the corpus callosum, absence of the commissura anterior, absence of the fornix and commissura fornicis, protuberance of the cortical tissue from the brain surface, and abnormal architecture of the hippocampus. An irregular mass of olfactory nerve was observed on the cribriform plate, and the olfactory bulb was deficient. From these findings, we considered Pdn/Pdn as a kind of arhinencephalic mouse. Nervous tissue-related proteins, S-100 alpha, S-100 beta, creatine kinase B (CK-B), neuron-specific gamma-enolase, guanosine triphosphate binding proteins (Go alpha, Gi2 alpha and G beta) were immunoassayed in the cerebrum of Pdn/Pdn embryos and newborns. Among the protein analysed, only S-100 beta of Pdn/Pdn showed a significantly lower level than that of +/+ cerebrum during the observation period. The newborn brains were examined immunohistochemically using S-100 alpha, S-100 beta, CK-B, Go alpha and NSE antibodies. We could find no differences in the staining patterns among the Pdn/Pdn, Pdn/+ and +/+ brains.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2323034     DOI: 10.1016/0165-3806(90)90283-5

Source DB:  PubMed          Journal:  Brain Res Dev Brain Res        ISSN: 0165-3806


  7 in total

1.  Neocortical origin and tangential migration of guidepost neurons in the lateral olfactory tract.

Authors:  N Tomioka; N Osumi; Y Sato; T Inoue; S Nakamura; H Fujisawa; T Hirata
Journal:  J Neurosci       Date:  2000-08-01       Impact factor: 6.167

2.  The doublesex homolog Dmrt5 is required for the development of the caudomedial cerebral cortex in mammals.

Authors:  Amandine Saulnier; Marc Keruzore; Sarah De Clercq; Isabelle Bar; Virginie Moers; Dario Magnani; Tessa Walcher; Carol Filippis; Sadia Kricha; Damien Parlier; Laurène Viviani; Clinton K Matson; Yasushi Nakagawa; Thomas Theil; Magdalena Götz; Antonello Mallamaci; Jean-Christophe Marine; David Zarkower; Eric J Bellefroid
Journal:  Cereb Cortex       Date:  2012-08-23       Impact factor: 5.357

3.  Gli3 controls corpus callosum formation by positioning midline guideposts during telencephalic patterning.

Authors:  Dario Magnani; Kerstin Hasenpusch-Theil; Carine Benadiba; Tian Yu; M Albert Basson; David J Price; Cécile Lebrand; Thomas Theil
Journal:  Cereb Cortex       Date:  2012-10-04       Impact factor: 5.357

4.  The mouse mutant Polydactyly Nagoya (Pdn) defines a novel allele of the zinc finger gene Gli3.

Authors:  T Schimmang; S I Oda; U Rüther
Journal:  Mamm Genome       Date:  1994-06       Impact factor: 2.957

5.  Developmental expression of glial markers in ependymocytes of the rat subcommissural organ: role of the environment.

Authors:  L Chouaf; M Didier-Bazes; H Hardin; M Aguera; M Fevre-Montange; B Voutsinos; M F Belin
Journal:  Cell Tissue Res       Date:  1991-12       Impact factor: 5.249

6.  The ciliogenic transcription factor RFX3 regulates early midline distribution of guidepost neurons required for corpus callosum development.

Authors:  Carine Benadiba; Dario Magnani; Mathieu Niquille; Laurette Morlé; Delphine Valloton; Homaira Nawabi; Aouatef Ait-Lounis; Belkacem Otsmane; Walter Reith; Thomas Theil; Jean-Pierre Hornung; Cécile Lebrand; Bénédicte Durand
Journal:  PLoS Genet       Date:  2012-03-29       Impact factor: 5.917

7.  Cerebral Cortex Expression of Gli3 Is Required for Normal Development of the Lateral Olfactory Tract.

Authors:  Eleni-Maria Amaniti; Alexandra Kelman; John O Mason; Thomas Theil
Journal:  PLoS One       Date:  2015-10-28       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.